Loading clinical trials...
Loading clinical trials...
Lymphatic Osteopathic Manipulative Medicine to Enhance COVID-19 Vaccination Efficacy
The purpose of this project is to study the impact of Osteopathic Manipulative Medicine (OMM) treatments, such as lymphatic myofascial release and thoracic pump techniques severe acute respiratory syndrome-associated coronavirus 2 (SARS-Cov-2) antibody levels in patients who receive the mRNA-1273 (Moderna) COVID-19 vaccine and to consider if these OMM strategies allow a stronger more robust immune response.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
Yes
Rowan University School of Osteopathic Medicine
Stratford, New Jersey, United States
Start Date
February 14, 2021
Primary Completion Date
February 28, 2023
Completion Date
February 28, 2023
Last Updated
October 3, 2022
Lymphatic OMM
OTHER
Light Touch
OTHER
Lead Sponsor
Rowan University
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT06631287